Estimates Revisions Palvella Therapeutics, Inc.
Stocks
PVLA
US6979471090
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
22:51:03 19/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 143.76 USD | -4.42% |
|
-6.88% | +37.96% |
| 08-04 | Palvella Therapeutics, Inc., Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Palvella Therapeutics Q2 Net Loss Widens | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- PVLA Stock
- Consensus Palvella Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
